Latest Executive Remuneration News

Peel Mining has appointed a new leadership team with deep mining and capital markets expertise, aiming to unlock significant value from its copper and polymetallic assets in the prolific Cobar region. The company signals a strategic shift towards targeted exploration, regional consolidation, and disciplined growth.

Lion Selection Group Limited reported a robust $39.2 million net profit for the year ended July 2025, driven by strong mark-to-market gains and strategic investments in Australian mining companies. The company’s portfolio value nearly doubled, reflecting timely market moves and a focus on precious and base metals.

Washington H. Soul Pattinson sought shareholder approval for a significant performance rights grant to its proposed Topco CEO, Todd Barlow, receiving overwhelming proxy support at its recent General Meeting.

Brickworks Limited seeks shareholder approval for a key executive incentive as it moves forward with its $16.9 billion merger with Soul Patts, aiming to create a streamlined and powerful new ASX-listed entity.

Excelsior Capital Limited reports a sharp 98% drop in profit after tax for FY25 following the prior year’s $47.2 million gain from selling its CMI Electrical subsidiary. Despite this, the company declared a fully franked final dividend of 4.0 cents per share.

Firebrick Pharma reported a substantial increase in Nasodine Nasal Spray revenues in FY25, alongside a widening net loss driven by reduced R&D incentives and increased marketing investments. The company is advancing its international rollout with new licensing deals and board appointments.

Powerhouse Ventures Limited reported a striking 348.8% jump in profit after tax to $1.82 million for FY25, driven by strategic acquisitions and a robust investment portfolio. The company’s first operating cash profit and growth in net tangible assets signal a turning point in its transformation.

Tissue Repair Ltd reported a 27.3% revenue increase to $3.22 million for FY25, driven by new distribution deals and regulatory progress, while continuing to invest heavily in clinical trials and manufacturing scale-up, resulting in a $4.24 million loss.

SOCO Corporation Ltd reported a 3.6% revenue increase to $21.29 million for FY25, reversing prior losses with a modest net profit after tax. Operational improvements and strategic hires underpin the company’s renewed momentum.

EPX Limited reported a 17.2% increase in revenue to $15.27 million for FY2025, alongside an 18.7% rise in net loss to $5.75 million. The company expanded its energy management portfolio with the acquisition of UK-based Coda Cloud Limited and raised $5 million in equity to fuel growth.

Mayne Pharma reported a 5% revenue increase to $408.1 million for FY25 but posted a net loss of $93.8 million, narrowing from the prior year. The company’s planned acquisition by Cosette Pharmaceuticals faces legal hurdles, delaying completion.

Cluey Ltd reported a significantly reduced loss for FY25 alongside an 11% increase in new students and achieved positive operating cash flow in Q4, signaling progress in its path to profitability.